Can cooling patients reduce the amount of brain damage and disability caused by a stroke?
The EuroHYP-1 trial is a large, international clinical trial that will test whether a promising new intervention called ‘therapeutic hypothermia’ can improve the outcome for patients with ischemic stroke (a stroke caused by a blood clot).
Therapeutic hypothermia means lowering the body by a few degrees and it is used to protect the body tissues from damage when they are not receiving enough oxygen.
Within six hours of symptom onset, patients enrolled in the trial will have their core body temperature reduced to 34-35°C for 24 hours.
For latest information about the trial, please visit the EuroHYP-1 website.